Pharma News Archives - Page 3 of 3 - rfxcel.com

rfxcel to Exhibit, Discuss DSCSA VRS at HDA Seminar in Washington, D.C.

Reno, Nevada (October 16, 2019). rfxcel, the global leader in supply chain track and trace solutions and the pharma industry’s thought leader in the Verification Router Service (VRS), will exhibit at the Healthcare Distribution Alliance’s (HDA’s) 2019 Traceability Seminar October 21-23 at the Marriott Wardman Park Hotel in Washington, D.C.

The HDA is a sponsor of the seminar, an annual event that brings together healthcare supply chain leaders to learn more about implementation milestones of the Drug Supply Chain Security Act (DSCSA) — as well as innovative approaches and lessons learned — as distributors, manufacturers, and dispensers implement serialization and traceability technologies to further preserve the safety and security of the healthcare supply chain.

This year’s gathering occurs less than a month after the U.S. Food and Drug Administration (FDA) announced that it did “not intend to take action against wholesale distributors” that do not meet the DSCSA Saleable Returns Verification Requirement before November 27, 2020. This is a 1-year extension of the original deadline for wholesale distributors to verify a product identifier before further distributing a returned product.

rfxcel is leading an FDA pilot to measure VRS readiness, and is looking forward to hosting a discussion about the state of the VRS and the effects of the FDA’s deadline extension. The company will share the interim pilot report it has prepared for the FDA, which presents findings of the tests it has conducted across the VRS network of providers.

Herb Wong, rfxcel’s executive sponsor of the FDA VRS pilot, said, “We’re excited to talk about VRS and share the findings of our pilot. We also want to talk about the deadline extension, which we believe is the right decision because it will allow the industry to test more production-like scenarios. When you’re at the Traceability Seminar, visit our team at Booth 9 to talk about all the latest developments. No matter what, companies should continue with their planned VRS implementation efforts so they’ll benefit from the continued testing.”

rfxcel began its FDA-approved VRS pilot in June. It is designed to quantify the readiness of the VRS network to meet the DSCSA’s Saleable Returns Verification Requirement. The pilot builds on the HDA’s VRS efforts and will systematically verify, measure, and report on the ability of the VRS network to meet the functional requirements of VRS.

A key and unique aspect of the pilot is that rfxcel has been sharing the details of its VRS test cases with all VRS providers to ensure they have a common detailed set of test cases. rfxcel will continue to work with the providers to verify the test conditions to enable maximum readiness of the VRS network across all VRS providers.

rfxcel CEO Glenn Abood said the company was honored to participate in the HDA seminar and would be prepared to field questions. “We’re the longest-tenured track and trace solution provider in the pharma industry and the thought leader in VRS,” he said. “We’re ready to share our expertise and discuss our VRS pilot to measure and ensure the seamless interoperability between VRS providers across a broad range of use cases. Recent developments don’t change the fact that complete and consistent verification of the use cases is critical to successfully meeting the DSCSA Saleable Returns Verification Requirement. Companies should remain on course and use the extra time to ensure they’re ready for 2020.”

To learn more about rfxcel’s FDA VRS pilot, its VRS solution, and other innovative track and trace products, visit the company at Booth 9, contact Herb Wong directly, or book a meeting at rfxcel.com.

 

Herb Wong, VP of Marketing

hwong@rfxcel.com

925-824-0300

 

About rfxcel

rfxcel is a track and trace software provider with leading-edge solutions to help organizations track their entire supply chain, meet regulatory compliance requirements, and protect products and brand reputations. For the last 15 years, manufacturers, wholesalers, distributors, and dispensers have trusted rfxcel to provide complete compliance and traceability solutions. rfxcel’s integrated track and trace software suite delivers better business outcomes and lowers supply chain costs. The company is headquartered in the United States and has offices in the EU, Latin America, India, Russia, the Middle East, Japan, and the Asia-Pacific region.

Walmart EVP and Amgen SVP Join rfxcel’s Board of Directors

San Ramon, CA  July 18, 2018 – rfxcel, leading track and trace software provider, announced today that Chris Sultemeier, formerly from Walmart, and Martin Van Trieste, formerly from Amgen, have joined rfxcel’s Board of Directors.

Chris Sultemeier brings over 30 years of leadership experience in supply chain operations to the rfxcel organization.  Chris was the Executive Vice President of Logistics at Walmart, as well as the President and CEO of Walmart Transportation LLC. During his tenure, he was responsible for all domestic and global distribution and fulfillment.  Chris received the prestigious Sam M. Walton Entrepreneur of the Year Award for his efforts on sustainability. Chris also serves as an instructor at MIT’s (Massachusetts Institute of Technology) Master’s Degree program for Supply Chain/Logistics/Transportation.

“I spent a life time working to improve supply chain efficiency; working with the industry leader, Walmart, I was fortunate to spearhead many new innovations which have now become common place.” says, Chris Sultemeier.  “I look forward to bringing this experience to a new leader, rfxcel, who will bring improved visibility and control to the supply chain across a wide-range of industries.”

“Chris’s expansive knowledge of supply chain tracking and optimization, combined with rfxcel’s world-class traceability platform will bring new business value to many organizations.  Chris’s vision and enthusiasm for transforming the supply chain is infectious and I am excited to welcome him to the rfxcel’s Board of Directors.”, says Glenn Abood, CEO.

Also joining the rfxcel board is Martin Van Trieste.  He is currently the Immediate Past Chair of the Parenteral Drug Association (PDA) which is committed to developing scientifically sound, practical technical information, and expertise to advance pharmaceutical and biopharmaceutical manufacturing science and regulation so members can better serve patients.

Martin’s experience includes serving as Chief Quality Officer and SVP of Quality at Amgen, as well as VP of Quality at a number of large biopharmaceutical companies. Martin’s decades of experience provide rfxcel with a varied and comprehensive knowledge of the industry.

“I am excited to join rfxcel in its mission to provide serialization, and track and trace technology to protect patients and consumers.  As a former SVP of Quality, I was drawn to rfxcel because of its commitment to quality.  rfxcel’s solution provides the most extensive verification of data in the industry. This commitment to quality data is essential to protecting consumers and the supply chain.”

“rfxcel has had the privilege of working with Martin over a number of years.  He has demonstrated the capacity to think strategically and deliver tactically.  We look forward to the new insights and leadership that Martin will bring to the rfxcel’s Board of Directors.”  said Glenn Abood, CEO.

 

For more information about rfxcel’s Board of Directors:

Herb Wong, VP of Marketing

hwong@rfxcel.com

www.rfxcel.com

 

About rfxcel:

rfxcel is the leading provider of SaaS-based track and trace solutions. Their platform enables companies to protect patients, comply with regulatory mandates, and gain visibility into their supply chain. rfxcel’s relentless commitment to customer success and continuous innovation ensures that companies can meet today’s requirements and tomorrow’s challenges.

Walmart, rfxce'sl Board of directors

rfxcel Drives LATAM Expansion

rfxcel announced today that they will expand their capability to enable LATAM Life Science(s) organizations to meet serialization and regulatory compliance requirements throughout Latin America and around the globe.

rfxcel is excited to announce the addition of Vinicius (Vinnie) Bagnarolli to their growing team of industry experts. Vinnie will be serving as the Commercial Director for Latin America. He will be responsible for driving rfxcel’s overall sales strategy and offerings to both existing and new clients throughout the region.

Vinnie joins rfxcel with an impressive resume; he has played leading roles with organizations such as Dell and Oracle. Prior to studying International Business Management in Canada, Vinnie managed a “technology stack” (Database, Middleware and Business Intelligence) division in São Paulo, Brazil that served both the Health Care and Life Sciences industries. Vinnie credits his success to his belief in educating both himself and his customers to be a reference in the industry. Most recently, he managed a Healthcare Global Business Unit and reported directly to the VP of Sales at Oracle’s headquarters in Redwood City, CA.

“rfxcel’s mission is a great fit for Latin America” says Vinnie. “We need companies that want to thrive and who want to help people – rfxcel’s expansion into LATAM and around the globe is making a positive impact on society.” Vinnie went on to say “Being part of an organization that puts their customers first and helps ensure products are safer and free from counterfeits is something that I am proud to be a part of.”

As the pioneer and a leader of track and trace solutions for the Life Sciences industry, rfxcel provides a robust product platform as well as a full-service implementation/support model, that ensures customer success, patient safety and peace of mind. rfxcel would like to officially welcome Vinnie to the Team, and we look forward to the opportunity to help fulfill the serialization and compliance needs throughout Latin American countries.